Back
Basilea Pharmaceutica 10K Form
Sell
50
BPMUF
Basilea Pharmaceutica
Last Price:
52.83
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BPMUF News And Ratings
See the #1 stock for the next 7 days that we like better than BPMUF
BPMUF Financial Statistics
Sales & Book Value
| Annual Sales: | $175.55M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 68.8 |
| Annual Sales: | $1.54 |
| Price / Book: | 34.29 |
Profitability
| EPS (TTM): | -0.23950 |
|---|---|
| Net Income (TTM): | $-1.2M |
| Gross Margin: | $145.71M |
| Return on Equity: | -15.42% |
| Return on Assets: | -0.54% |
Basilea Pharmaceutica Earnings Forecast
Key Basilea Pharmaceutica Financial Ratios
- The Gross Profit Margin over the past 17 years for BPMUF is 83.00%.
- The Selling, General & Administrative Expenses for BPMUF have been equal to 21.43% of Gross Profit Margin.
- The Research & Development expenses have been 49.39% of Revenue.
- The Interest Expense is 107.19% of Operating Income.
- The Net Earning history of BPMUF is 6.63% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 11 years.
Basilea Pharmaceutica Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BPMUF |
| Website: | basilea.com |
Debt
| Debt-to-Equity Ratio: | 5.7 |
|---|---|
| Current Ratio: | 4.1 |
| Quick Ratio: | 2.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 55.16 |
|---|---|
| Forward P/E Ratio: | 0 |
BPMUF Technical Analysis vs Fundamental Analysis
Sell
50
Basilea Pharmaceutica (BPMUF)
is a Sell
Is Basilea Pharmaceutica a Buy or a Sell?
-
Basilea Pharmaceutica stock is rated a Sell
The current Basilea Pharmaceutica [BPMUF] share price is $52.83. The Score for BPMUF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.